Showing results (521-530 of 687) with videos related to
Sort By:
Pageof 69
Plos One|November 23, 2021
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot studyAtul Goyale, Anjly Jain, Colette Smith, et al.Vascular|October 14, 2021
Incidence of contrast-induced acute kidney injury in patients with acute mesenteric ischemia and identification of potential predictive factorsEmmanuel Augène, Fabien Lareyre, Julien Chikande, et al.The Open Cardiovascular Medicine Journal|October 4, 2011
Prevalence, Predictors, and Impact of Low High-Density Lipoprotein Cholesterol on in-Hospital Outcomes Among Acute Coronary Syndrome Patients in the Middle EastKhalid Al-Rasadi, Ibrahim Al-Zakwani, Mohammad Zubaid, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2004
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) studyVasilios G Athyros, Moses Elisaf, Athanasios A Papageorgiou, et al.In Vivo (Athens, Greece)|August 22, 2007
Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equationEmmanuel S Ganotakis, George E Vrentzos, Irene F Gazi, et al.Expert Opinion on Pharmacotherapy|July 1, 2011
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemiaAris P Agouridis, Vasilis Tsimihodimos, Theodosios D Filippatos, et al.In Vivo (Athens, Greece)|April 17, 2009
Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart diseaseGenovefa D Kolovou, Katherine K Anagnostopoulou, Peggy Kostakou, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 24, 2006
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrateDimitrios S Christidis, Evangelos N Liberopoulos, Anna I Kakafika, et al.Journal of Cachexia, Sarcopenia and Muscle|October 13, 2018
Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditionsPeter E Penson, G B John Mancini, Peter P Toth, et al.Journal of Psychosomatic Research|July 14, 2010
Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS StudyJakub Kazmierski, Maciej Kowman, Maciej Banach, et al.Pageof 69